Shenzhen Drawray Biotech Co., Ltd. was established in May 2019. The company is mainly engages in the R&D, production, sales and service of products in the field of diagnostics (IVD).
Draway has five in-vitro diagnostic technology platforms including Mono-test CLIA, FIA, Microfluidics, Rapid Test and PCR. Its products cover cardiac markers, thyroid function, endocrine hormones, autoimmunity, respiratory viruses, reproductive health, bone metabolism, inflammation and infection, liver disease monitoring, allergen detection and other diagnosis fields. With continuous involvement in research and development every year, we have achieved over 90 CE and more than 40 patents.
Company Details
- Employees
- 13
- Founded
- -
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://en.szdrawray.com/
- Keywords
- IVD and Immunology.
Drawray Questions
Drawray's website is http://en.szdrawray.com/
Drawray's LinkedIn profile is https://www.linkedin.com/company/drawray
Drawray has
13 employees.
View email and phone details for 13
employees at Drawray.
Drawray's industry is
Medical Equipment Manufacturing
Drawray's top competitors are
Dymind,
Lifotronic,
Autobio Diagnostics,
Eaglenos Sciences, Inc.,
Comen,
Biotime,
Dirui,
Yhlo,
Maccura,
Zybio Inc..
Drawray's categories are Medical Equipment Manufacturing
Drawray's founding year is 2019
